Advanced search
Publication Cover
Future Rare Diseases Volume 4, 2023 - Issue 1
Submit an article Journal homepage
85
Views
0
CrossRef citations to date
0
Altmetric
Plain Language Summary of Publication

Study design of BI 1015550 for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: a plain language summary

Toby M Maher1 Keck Medicine of USC, Los Angeles, CA, USA;2 National Heart & Lung, Institute, Imperial College London, London, UK
,
Arata Azuma3 Pulmonary Medicine & Clinical Research Center, Mihara General Hospital, Saitama Japan;4 Pulmonary Medicine & Oncology, Nippon Medical School, Tokyo, Japan
,
Vincent Cottin5 Hôpital Louis Pradel, Centre Coordonnateur National de référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, UMR754, INRAE, Université Claude Bernard Lyon 1, member of ERN-LUNG, Lyon, France
,
Shervin Assassi6 Division of Rheumatology, McGovern Medical School, University of Texas, Houston, TX, USA
,
Anna-Maria Hoffmann-Vold7 Department of Rheumatology, Oslo University Hospital, Oslo, Norway
,
Michael Kreuter8 Mainz Center for Pulmonary Medicine, Department of Pneumology, Mainz University Medical Center, Mainz, Germany;9 Department of Pulmonary, Critical Care & Sleep Medicine, Marienhaus Clinic Mainz, Mainz, Germany
,
Fernando J Martinez10 Department of Medicine, Cornell University, New York City, NY, USA
,
Justin M Oldham11 University of Michigan, Pulmonary & Critical Care Medicine, Ann Arbor, MI, USA
,
Claudia Valenzuela12 ILD Unit, Pulmonology Department, Hospital Universitario de la Princesa, Universidad Autonomade Madrid, Madrid, Spain
,
Marlies S Wijsenbeek13 Centre for Interstitial Lung Diseases & Sarcoidosis, Department of Respiratory Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands
,
Yi Liu14 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA
,
Daniel Wachtlin15 Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany
,
Susanne Stowasser16 TA Inflammation Med, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany
,
Donald F Zoz14 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA
&
Luca Richeldi17 Unità Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
 show all
Article: FRD60 | Received 12 Jan 2023, Accepted 19 Jan 2024, Published online: 19 Feb 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.